carbidopa has been researched along with Ambulation Disorders, Neurologic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, L; Fasano, A; Femia, S; Gurevich, T; Kovács, N; Parra, JC; Sanchez-Soliño, O; Svenningsson, P; Szász, J; Vela-Desojo, L | 1 |
| Amato, F; Artusi, CA; Calandra-Buonaura, G; Contin, M; Cortelli, P; Giannini, G; Imbalzano, G; Ledda, C; Lopiano, L; Olmo, G; Rinaldi, D; Romagnolo, A; Sambati, L; Zibetti, M | 1 |
| Fung, VSC; Griffith, J; Mahant, N; Martin, AJ; Morales-Briceño, H; Tsui, D | 1 |
| Bloem, BR; Nonnekes, J | 1 |
| Bonvegna, S; Cilia, R; Colucci, F; Cossu, G; De Micco, R; Eleopra, R; Elia, AE; Fabbri, M; Ielo, GC; Lopiano, L; Modugno, N; Morgante, F; Novelli, A; Olivola, E; Oppo, V; Pilleri, M; Ricciardi, L; Sensi, M; Sorbera, C; Tessitore, A; Zibetti, M | 1 |
| Fujioka, S; Komorita, S; Mishima, T; Nishida, A; Okajima, M; Tsuboi, Y | 1 |
| Angrisano, S; Artusi, CA; Dematteis, F; Lopiano, L; Merola, A; Romagnolo, A; Zibetti, M | 1 |
| Chang, FC; Drury, M; Fung, VS; Griffith, JM; Ha, AD; Kim, SD; Mahant, N; Tsui, DS; Wolfe, N | 1 |
| Guertin, PA; Rouleau, P; Ung, RV | 1 |
| Tarsy, D | 1 |
| Minagar, A; Shulman, LM; Weiner, WJ | 1 |
| Weiner, WJ | 1 |
| Cheyette, BN; Cheyette, SN; Cusmano-Ozog, K; Enns, GM | 1 |
1 review(s) available for carbidopa and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Motor fluctuations in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Motor Activity; Neurosurgical Procedures; Parkinson Disease; Tremor | 2006 |
12 other study(ies) available for carbidopa and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS).
Topics: Antiparkinson Agents; Carbidopa; Cross-Sectional Studies; Drug Combinations; Gait Disorders, Neurologic; Gels; Humans; Levodopa; Parkinson Disease; Quality of Life; Retrospective Studies | 2022 |
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesias; Gait Disorders, Neurologic; Gels; Humans; Levodopa; Middle Aged; Parkinson Disease; Posture | 2023 |
"On-State" Freezing of Gait: Insights and Treatment With Levodopa Intestinal Gel Infusion.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gait; Gait Disorders, Neurologic; Gels; Humans; Levodopa; Parkinson Disease | 2020 |
Biphasic Levodopa-Induced Freezing of Gait in Parkinson's Disease.
Topics: Aged; Carbidopa; Dopamine Agonists; Drug Combinations; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease | 2020 |
Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cross-Sectional Studies; Drug Combinations; Gait Disorders, Neurologic; Gels; Humans; Italy; Levodopa; Parkinson Disease; Quality of Life | 2021 |
[Optimal dose of levodopa-carbidopa intestinal gel in the treatment of diphasic dyskinesia and freezing of gait].
Topics: Activities of Daily Living; Carbidopa; Dyskinesias; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Middle Aged; Parkinson Disease | 2021 |
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait Disorders, Neurologic; Gels; Humans; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2018 |
24 h Levodopa-carbidopa intestinal gel may reduce falls and "unresponsive" freezing of gait in Parkinson's disease.
Topics: Accidental Falls; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait Disorders, Neurologic; Gels; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Time Factors | 2015 |
Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy.
Topics: Administration, Oral; Animals; Biological Clocks; Buspirone; Carbidopa; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Feasibility Studies; Gait Disorders, Neurologic; Levodopa; Male; Mice; Paraplegia; Serotonin Receptor Agonists; Spinal Cord | 2010 |
Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease.
Topics: Amantadine; Antiparasitic Agents; Carbidopa; Catechols; Decision Making; Deep Brain Stimulation; Disease Progression; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Quality of Life; Subthalamus | 2012 |
Reversal of parkinsonism following liver transplantation.
Topics: Acute Disease; Aged; Antiparkinson Agents; Carbidopa; Disease Progression; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Remission Induction; Treatment Outcome; Tremor | 2003 |
Dopa-responsive dystonia presenting as delayed and awkward gait.
Topics: Carbidopa; Child, Preschool; Dopamine Agonists; Drug Combinations; Dystonic Disorders; Gait Disorders, Neurologic; GTP Cyclohydrolase; Humans; Levodopa; Male; Mutation; Pedigree | 2008 |